About UCB (OTCMKTS:UCBJF)
UCB SA, a biopharmaceutical company, focuses on the discovery and development of medicines and solutions for people living with severe diseases of the immune system or of the central nervous system. Its core products include Cimzia for ankylosing spondylitis, axial spondyloarthritis, Crohns disease, psoriatic arthritis, and rheumatoid arthritis; Keppra, Vimpat, and Briviact for epilepsy; and Neupro for Parkinsons disease and restless legs syndrome. The company also offers Zyrtec and Xyzal for allergy; Venlafaxine ER for depressive and anxiety disorders; Nootropil for cognitive disorders; and Xyrem for narcolepsy. Its product pipeline includes UCB0942 for highly drug resistant epilepsy; dapirolizumab pegol for systemic lupus erythematosus; bimekizumab for various indications; bimekizumab, add-on to Cimzia for rheumatoid arthritis; seletalisib for Sjögrens syndrome; UCB7665 for immune thrombocytopenia; UCB1332 for Parkinsons disease; UCB4144/VR942 for asthma; UCB6673 for immunological diseases; UCB3491 for epilepsy; and UCB7858 for auto-inflammatory diseases. UCB SA was founded in 1928 and is headquartered in Brussels, Belgium.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E Ratio16.26
Sales & Book Value
Annual Sales$4.55 billion
Price / Sales3.64
Cash Flow$3.36 per share
Price / Cash25.32
Book Value$31.16 per share
Price / Book2.73
Return on EquityN/A
Return on AssetsN/A
UCB (OTCMKTS:UCBJF) Frequently Asked Questions
What is UCB's stock symbol?
UCB trades on the OTCMKTS under the ticker symbol "UCBJF."
Who are some of UCB's key competitors?
Some companies that are related to UCB include Fresenius Medical Care AG & Co. (FMS), McKesson (MCK), Actelion (ALIOF), Essilor International (ESLOY), Astellas Pharma (ALPMY), Zimmer Biomet (ZBH), Mylan (MYL), Cardinal Health (CAH), AmerisourceBergen (ABC), Lonza Group (LZAGY), Sunny Optical Tech (SNPTF), Centene (CNC), Coloplast A/S (CLPBY), IDEXX Laboratories (IDXX), Smith & Nephew (SNN), Eisai (ESALY), BioMarin Pharmaceutical (BMRN) and Nektar Therapeutics (NKTR).
How do I buy UCB stock?
Shares of UCB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is UCB's stock price today?
One share of UCB stock can currently be purchased for approximately $85.06.
How big of a company is UCB?
UCB has a market capitalization of $16.54 billion and generates $4.55 billion in revenue each year.
How can I contact UCB?
UCB's mailing address is 60 ALLEE DE LA RECHERCHE, BRUSSELS C9, 1070. The company can be reached via phone at 32-2559-9999 or via email at [email protected]
MarketBeat Community Rating for UCB (UCBJF)MarketBeat's community ratings are surveys of what our community members think about UCB and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
UCB (OTCMKTS:UCBJF) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for UCB (OTCMKTS:UCBJF)
No earnings announcements for this company have been tracked by MarketBeat.com
UCB (OTCMKTS:UCBJF) Earnings Estimates
Current Year EPS Consensus Estimate: $5.23 EPS
Next Year EPS Consensus Estimate: $5.64 EPS
Dividend History for UCB (OTCMKTS:UCBJF)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for UCB (OTCMKTS UCBJF)
No insider trades for this company have been tracked by MarketBeat.com
UCB (OTCMKTS UCBJF) News Headlines
UCB (OTCMKTS:UCBJF) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
UCB (OTCMKTS UCBJF) Stock Chart for Friday, February, 23, 2018